Abstract

Jyoti Sharma and Ripu Daman

DOI : http://dx.doi.org/10.13005/ojc/380415

Psoriasis is a dermal condition caused by an immunological response. Interrelations among the innate and adaptive immunological responses are the fundamental cause to trigger the pathogenesis of the psoriatic plague. The study of psoriasis pathophysiology has greatly advanced our understanding of epidermal physiology. Advancements in psoriasis etiology have paved the way for effective tailored and specialized drugs, revealing invaluable discernment into the pathophysiology of the chronic inflammatory dermal condition. In this review, we discuss the clinical classification, identification, and management of psoriasis. Further, we will briefly discuss the hurdles in the conventional treatment and how various nano-based carriers used in the drug delivery are able to overcome them. The clinical categorization, detection, and management of psoriasis are discussed in this review. Further, we'll discuss the limitations of conventional treatment and the advantages of nan-drugs over them.

Drug Delivery; Nanocarriers; Pustular Psoriasis; Psoriasis; Topical Treatment

[ View HTML Full Text]